By the end of this BC ECHO on Substance Use session, participants will be able to:
1) describe the evidence for iOAT in treating opioid use disorder,
2) incorporate iOAT as part of the continuum of care for opioid use disorder,
3) evaluate patients for initiating iOAT, and
4) safely initiate and titrate iOAT, and provide ongoing clinical support to a patient on iOAT.
Management of Opioid Use Disorder with Injectable Opioid Agonist Treatment (iOAT)
Past Session
Thursday, June 24 2021, 12:00pm to 1:00pm PT
Presented by Dr. Rupi Brar & Dr. Marie-Ève Goyer